November 23, 2011

SEBIO Announces Winners of Regional Deal of the Year Awards

Filed under: SEBIO News — admin @ 12:04 pm

Atlanta, GA - The winners of Southeast BIO’s (SEBIO) Southeast Deal of the Year awards were announced in a ceremony held at its 13th Annual Investor Forum in Durham, North Carolina on November 3rd. Companies honored at the fifth annual awards ceremony competed in the following categories:

• Initial Funding
• Venture Capital Transaction
• Strategic Transaction
• Strategic Investment

The winners were Sebacia, Inc., Chimerix, Inc., ArtusLabs, and Liquidia Technologies.

“Each year SEBIO recognizes rising companies, key business transactions and business leaders in the Southeast US life science community,” said Ken Tindall, past Chair of SEBIO and Sr. Vice President for Science and Business Development at the North Carolina Biotechnology Center. “The region enjoyed a very successful year in life science business activities. SEBIO award winners as well as all those competing in the EARLY/Stage Shootout and BIO/Plan Competition are a measure of the strong companies, exciting new technologies and mature executive leadership contributing to the development of a robust industry across the region.“

Sebacia, Inc., a medtech start-up founded in 2010, won the Southeast Deal of the Year: Initial Funding award for raising nearly $5.6 million earlier this year. Sebacia is developing novel technology to address a large unmet need in dermatology and is currently operating within The Innovation Factory (TIF). TIF is a privately funded health-care incubator based in Duluth, Georgia. Investors in Sebacia include Accuitive Medical Ventures, Versant Ventures, Domain Associates and the Partners Healthcare Innovation Fund.

Chimerix, Inc. won the Southeast Deal of the Year: Venture Capital Transaction award. Chimerix is developing orally available antiviral therapeutics and was recognized for the closing of a $45 million, sixth round of financing in February. New Leaf Venture Partners, Pappas Ventures and Morningside Group, as well as existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures all participated in the funding. Chimerix has raised more than $160 million in venture capital and government funding since its inception.

ArtusLabs was voted the winner of the Southeast Deal of the Year: Strategic Transaction award. ArtusLabs, a Morrisville, North Carolina-based company, was acquired by PerkinElmer earlier this year for an undisclosed amount. Venture-backed ArtusLabs offers the Ensemble scientific knowledge platform, to accelerate research and development in the pharmaceutical, chemical, petrochemical and related industries. Investors in ArtusLabs include Southern Capitol Ventures and Hatteras Venture Partners.

Liquidia Technologies received the Southeast Deal of the Year: Strategic Investment award for its receipt of a $10 million investment from the Bill & Melinda Gates Foundation. This represents the first ever equity investment by the Foundation in a privately held biotechnology company. Liquidia Technologies is developing highly precise particle-based vaccines and therapeutics for the prevention and treatment of human disease. Utilizing a novel technology known as the PRINT platform, Liquidia is creating rationally designed carriers for improved delivery of small molecule and biological cargos.

The Southeast Leadership Award was also presented at the event. This honor, which goes to an individual or organization that has made a notable contribution to the growth of the life sciences industry in the region, was bestowed upon William Brooke of Harbert Management Corporation.

Will was selected for his leadership in SEBIO as a past Chairman and board member and for helping to bring SEBIO to a new organizational level with a broad range of stakeholders, clearly established goals, and executive leadership. Will has been a significant contributor to the growth of the regional life sciences industry as a Managing Partner and founder of Harbert Management Corporation and investor in numerous Southeast life sciences companies. Will serves on the boards of Aldagen, Innovative Biosensors, MaxCyte and nContact, as well as SEBIO, Innovation Depot, Biotechnology Association of Alabama, and Alabama Innovation Council. He has previously served on the boards of NovaMin, AV Holdings (Atherotech), Visador, Nationwide Homes and Emageon.

The Sixth Annual SEBIO Awards Ceremony will be held during the 2012 Southeast BIO Investor Forum on October 31 – November 1, 2012, at the Breakers Resort in Palm Beach, Florida. Further details will be posted on the SEBIO web site (www.sebio.org).

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment